This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (775)
-
December 02, 2025 | Insight Seagen antibody-drug conjugate patent suffers dual defeats on appeal in US
...Sanofi the ‘039 patent also suffers from a lack of enablement....
Sections: Intellectual Property
-
November 27, 2025 | Insight This week at the UPC: Nov. 21-27
...The judgment confirm the court’s test for assessing inventive step established in Amgen v Sanofi.Judges...
Sections: Intellectual Property
-
November 27, 2025 | Insight Edwards wins UPC appeal, court confirms inventive step test
...UPC — the same framework it set out earlier the same day in its ruling for the case between Amgen and Sanofi...
Sections: Intellectual Property
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login